Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

New mouse models of Pemphigus show severe symptoms and need better treatments.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Low-dose oral minoxidil may help with symptoms and hair regrowth in lichen planopilaris without serious side effects.

FucoPol hydrogel membranes are promising for delivering drugs on the skin.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Baricitinib is more effective than methotrexate for severe alopecia areata.

A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.

A new topical treatment using micelles shows promise for safer and more effective hair regrowth in androgenetic alopecia.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Combining either fractional CO2 laser or microneedling with 5-FU is more effective for treating vitiligo.

Some skin growths with mucin can form hair follicles and resemble skin cancer, but a special stain can help tell them apart.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Finasteride's effectiveness for frontal fibrosing alopecia is uncertain.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Using sunscreen and moisturizers may increase the chance of developing Frontal fibrosing alopecia (FFA), but the exact reason why is still unclear.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

The optimized microemulsion with cinnamon oil effectively delivers finasteride through the skin without damaging hair.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The formulated gel is a promising treatment for alopecia areata.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Tofacitinib is an effective and safe treatment for alopecia areata.

PPCM microspheres can effectively release finasteride over 42 days.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.